PRKCH Recombinant Monoclonal Antibody

說明書

中文名稱：

PRKCH Recombinant Monoclonal Antibody
貨號：

CSB-RA877922A0HU
規格：

￥1320
圖片：
Flow cytometric analysis of Protein kinase C eta expression in HepG2 cells using Protein kinase C eta antibody. Green, isotype control; red, Protein kinase C eta.

Immunocytochemical staining of HepG2 cells with Protein kinase C eta antibody. Nuclei were stained blue with DAPI; Protein kinase C eta was stained magenta with Alexa Fluor? 647. Images were taken using Leica stellaris 5. Protein abundance based on laser Intensity and smart gain: Medium. Scale bar: 20 μm.

Western blotting analysis using Protein kinase C eta antibody. Total cell lysates (30 μg) from various cell lines were loaded and separated by SDS-PAGE. The blot was incubated with Protein kinase C eta antibody and HRP-conjugated goat anti-rabbit secondary antibody respectively.
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

Uniprot No.：

P24723
基因名：

PRKCH
別名：

PRKCH; Protein Kinase C Eta; PKC-L; PKCL; PRKCL; Protein Kinase C Eta Type; Protein UPEP; EC 2.7.11.13; NPKC-Eta; UORF2; PRKCH Upstream Open Reading Frame 2; Protein Kinase C, Eta; EC 2.7.11
反應種屬：

Human, Rat
免疫原：

Recombinant Human PRKCH protein
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
克隆類型：

Monoclonal
抗體亞型：

Rabbit IgG
純化方式：

Affinity-chromatography
克隆號：

25C7
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Rabbit IgG in PBS (pH 7.4) containing 50% glycerol, and 0.02% sodium azide.
產品提供形式：

Liquid
應用范圍：

ELISA, WB, FC, ICC

推薦稀釋比：

Application	Recommended Dilution
WB	1:1000-1:5000
FC	1:200-1:2000
ICC	1:100-1:1000

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
Flow cytometry (FC) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in the regulation of cell differentiation in keratinocytes and pre-B cell receptor, mediates regulation of epithelial tight junction integrity and foam cell formation, and is required for glioblastoma proliferation and apoptosis prevention in MCF-7 cells. In keratinocytes, binds and activates the tyrosine kinase FYN, which in turn blocks epidermal growth factor receptor (EGFR) signaling and leads to keratinocyte growth arrest and differentiation. Associates with the cyclin CCNE1-CDK2-CDKN1B complex and inhibits CDK2 kinase activity, leading to RB1 dephosphorylation and thereby G1 arrest in keratinocytes. In association with RALA activates actin depolymerization, which is necessary for keratinocyte differentiation. In the pre-B cell receptor signaling, functions downstream of BLNK by up-regulating IRF4, which in turn activates L chain gene rearrangement. Regulates epithelial tight junctions (TJs) by phosphorylating occludin (OCLN) on threonine residues, which is necessary for the assembly and maintenance of TJs. In association with PLD2 and via TLR4 signaling, is involved in lipopolysaccharide (LPS)-induced RGS2 down-regulation and foam cell formation. Upon PMA stimulation, mediates glioblastoma cell proliferation by activating the mTOR pathway, the PI3K/AKT pathway and the ERK1-dependent phosphorylation of ELK1. Involved in the protection of glioblastoma cells from irradiation-induced apoptosis by preventing caspase-9 activation. In camptothecin-treated MCF-7 cells, regulates NF-kappa-B upstream signaling by activating IKBKB, and confers protection against DNA damage-induced apoptosis. Promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria. Phosphorylates ATF2 which promotes its nuclear retention and transcriptional activity and negatively regulates its mitochondrial localization.
基因功能參考文獻：
1. These results suggest that PKCeta utilizes the ERK signaling pathway to protect against ubiquitin-mediated proteasomal degradation of Mcl-1 PMID: 28939105
2. PRKCH rs2230500 gene polymorphism is significantly related to the efficiency in telmisartan therapy (p = 0.02). The PRKCH rs2230500 may influence the antihypertensive efficacy of telmisartan in Chinese EH patients. PMID: 28640647
3. PRKCH is highly expressed in hematopoietic stem cell (HSC) and is necessary for optimal HSC function. PMID: 28596089
4. The association between PRKCH 1425G/A and lacunar infarction was independent of traditional stroke risk factors PMID: 25900926
5. variant genotypes of PRKCH 1425G/A are an independent prognostic factor for ischemic stroke in the final multivariate Cox regression model PMID: 25370935
6. Meta-analysis indicated that the 1425G/A SNP in PRKCH may contribute to susceptibility of stroke, especially for ischemic stroke. PMID: 25272991
7. PKCeta promotes senescence through its ability to upregulate the expression of the cell cycle inhibitors p21Cip1 and p27Kip1 and enhance transcription and secretion of IL-6. PMID: 25412309
8. The 1425G/A polymorphism in PRKCH is not a significant predictor of stroke recurrence in patients with acute ischemic stroke during a 2-year follow-up period. PMID: 24534126
9. PKC-eta associates with NHE3 and gamma tubulin to promote the cell polarity during migration. PMID: 24788043
10. These results suggest that siRNA-mediated silencing of PKCeta can be a potent tool to complement existing chemotherapy regimens for treating EBV(+) B lymphoma. PMID: 24784886
11. the PKC family genes may play a role in the pathogenesis of MS relapse through modulating the association between 25(OH)D and relapse. PMID: 23868949
12. study demonstrates that type V collagen induces the down-regulation of protein kinase C eta PMID: 22213077
13. these results suggest that the regulation of PKCeta is unique and PKCepsilon is required for the PKC activator-induced upregulation of PKCeta. PMID: 22892130
14. The single nucleotide polymorphism (rs2230500) in PRKCH decreases the risk of carotid intima-media thickness. PMID: 22808203
15. There was loss of the negative correlation in the expression levels of CD3eta and FcepsilonRIgamma genes in CLL patients. PMID: 22664044
16. Protein kinase Ceta 1425G/A variant was not a risk locus for deep intracerebral hemorrhage phenotype. PMID: 22999931
17. It was shown that the PKCeta isoform is a negative regulator of the AKT signaling pathway. The IGF-I induced phosphorylation on Ser473 of AKT was inhibited by the PKCeta-induced expression in MCF-7 breast adenocarcinoma cancer cells. PMID: 22305966
18. A remarkable association of minor alleles (1425G/A and _15) in the PRKCH gene with an elevated risk of coronary artery disease and increased levels of LDL-C in a Chinese population. PMID: 21625852
19. The present meta-analyses suggested that 1425G/A SNP in PRKCH was associated with ischemic stroke, particularly lacunar infarction, in Chinese and Japanese populations. PMID: 22044875
20. In the present study, a significant association between the PRKCH 1425G/A polymorphism and SSNHL risk was observed through a nested case-control analysis within the population-based study. PMID: 21756056
21. study suggests that PKCeta is involved in NF-kappaB signaling leading to drug resistance. PMID: 21820409
22. Catalytic activity of protein kinase C eta (PKCeta) is not necessary for enlarged and flattened morphology of differentiated human keratinocytes, although it is important for gene expression of the marker proteins. PMID: 21346190
23. the AA genotype of PRKCH, relative to the G/G genotype, may be a higher risk genotype for severe gastric atrophy PMID: 20602195
24. Reduced expression of PKCeta may represent a molecular lesion in the development of more aggressive disease of human hepatocellular carcinoma. PMID: 20001341
25. that PKC eta negatively regulates UV-induced apoptosis through its localization, resistance to cleavage, and the p38 MAPK pathway PMID: 12646210
26. Minute virus of mice infection causes accumulation of endogenous PKCeta in the nuclear periphery and regulaties this NS1 regulating kinase, thus underlining the tight interconnection between PKC-mediated signaling and the parvoviral life cycle PMID: 12829844
27. The major result is a clear correlation of PKC eta expression with tumor progression in renal cell carcinoma. PMID: 14666709
28. There was expression of protein kinase C eta in abnormal muscle fibers. Protein kinase C isoforms may play a role in the pathogenesis of myofibrillar myopathy. PMID: 15159477
29. PKC-eta targets the Akt and mTOR signaling pathways PMID: 15489897
30. These studies demonstrate translocation of PKCeta to the nuclear envelope, and suggest that the spatial regulation of PKCeta could be important for its cellular functions including effects on cell cycle control and involvement in tumor promotion. PMID: 16242915
31. PKC-eta-mediated glioblastoma proliferation involves MEK/mitogen-activated protein (MAP) kinase phosphorylation, activation of ERK and subsequently of Elk-1. PMID: 17146445
32. Our results provide evidence of the involvement of PRKCH as a susceptibility gene for rheumatoid arthritis in the Japanese population PMID: 17195206
33. Fission of transport carriers at the trans-Golgi network is dependent on specifically PLCbeta3, which is necessary to activate PKCeta and PKD in that Golgi compartment, via diacylglycerol production. PMID: 17492941
34. PKCeta functions as an anti-apoptotic protein in Hodgkin's lymphoma-derived cell lines PMID: 17786031
35. PRKCH mRNA was expressed at lower level in rheumatoid arthritis unrelated patients than in healthy controls, and is not a rheumatoid arthritis major susceptibility genetic factor in the French Caucasian population. PMID: 17957454
36. PRKCH gene polymorphisms have a role in subcortical silent brain infarction PMID: 18164711
37. Results establish PKCeta as a unique element in interferon signaling that plays a key and essential role in the generation of the regulatory effects of type I IFNs on normal and leukemic hematopoiesis. PMID: 19211565
38. nPKCeta positively regulates agonist-induced thromboxane generation with no effects on platelet aggregation. PMID: 19286657
39. The 1425G/A SNP in PRKCH increases the risk of both ischemic stroke and cerebral hemorrhage in the Chinese population. PMID: 19520989
40. Data show that PKCeta is an anti-apoptotic protein, acting as a negative regulator of JNK activity. PMID: 19523467
41. Translational regulation could provide an additional level for controlling the expression of PKC family members. PMID: 19797084
42. We report that a nonsynonymous SNP in PRKCH increases the risk of cerebral infarction in the general Japanese population. We also found that PKCeta was expressed in vascular endothelial cells and foamy macrophages in human atherosclerotic lesions. PMID: 17206144
顯示更多

收起更多
相關疾病：

Ischemic stroke (ISCHSTR)
亞細胞定位：

Cytoplasm.
蛋白家族：

Protein kinase superfamily, AGC Ser/Thr protein kinase family, PKC subfamily
組織特異性：

Most abundant in lung, less in heart and skin.
數據庫鏈接：

HGNC: 9403

OMIM: 601367

KEGG: hsa:5583

STRING: 9606.ENSP00000329127

UniGene: Hs.333907

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VDR Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human